mounjaro tirzepatide patent expiration date Injection: Package Insert / Prescribing Info / MOA In weight loss battle, Novo – A Strategic Guide to Capitalizing

But most patients drop off the drugs before one year: Among GLP-1 patients with obesity who fill their first prescription, just 32% are still taking their medication 13 months later, per November IQVIA analysis

doi: 10.1002/oby.21107 25 VilsbllTKrarupTMadsbadSHolstJJ

Silva, Algera Goga, Geraldine O

For those interested in going on a GLP-1, it's crucial to talk to your doctor to get a comprehensive view of your health, assess the risks and decide if this medication is right for you

10.1101/2024.10.11.617524(Accessed March 7, 2025)

The practical impact is significant for practices serving Medicare Advantage populations